Market Overview
The Durable Medical Equipment (DME) Market size was valued at USD 228.92 million in 2024 and is anticipated to reach USD 334.37 million by 2032, at a CAGR of 4.85% during the forecast period.
| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2020-2023 |
| Base Year |
2024 |
| Forecast Period |
2025-2032 |
| Durable Medical Equipment (DME) Market Size 2024 |
USD 228.92 million |
| Durable Medical Equipment (DME) Market, CAGR |
4.85% |
| Durable Medical Equipment (DME) Market Size 2032 |
USD 334.37 million |
The durable medical equipment market features strong competition among global leaders such as Medtronic PLC, General Electric Company, Becton, Dickinson and Company, Stryker Corporation, Hill Rom, Getinge AB, and Resmed Inc. These companies dominate through innovation in patient mobility, monitoring, and therapeutic devices. North America led the market with a 38% share in 2024, supported by advanced healthcare systems, insurance coverage, and high adoption of home healthcare solutions. Europe followed with 29%, driven by robust reimbursement frameworks and growing elderly care needs, while Asia Pacific accounted for 23%, emerging as the fastest-growing region due to healthcare infrastructure expansion.
Market Insights
- The durable medical equipment market was valued at USD 228.92 million in 2024 and is projected to reach USD 334.37 million by 2032, growing at a CAGR of 4.85%.
- Rising prevalence of chronic diseases and the growing elderly population drive demand for oxygen equipment, glucose monitors, and mobility aids.
- Technological advancements in IoT-enabled monitoring and lightweight device designs are shaping the next phase of product innovation.
- The market remains highly competitive, with global players focusing on strategic partnerships and sustainable device development to enhance accessibility and affordability.
- North America led the market with a 38% share in 2024, followed by Europe with 29% and Asia Pacific with 23%, while monitoring and therapeutic devices accounted for the largest segment share of 42%.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Download Sample
Market Segmentation Analysis:
By Product
The monitoring and therapeutic devices segment dominated the durable medical equipment market with a 42% share in 2024. The segment’s growth is driven by rising demand for oxygen concentrators, infusion pumps, and CPAP devices due to increasing cases of chronic respiratory and cardiovascular conditions. Technological advancements in remote monitoring and portable oxygen systems have enhanced patient compliance and home-based care efficiency. The integration of IoT-enabled devices for continuous data tracking further strengthens adoption across hospitals and home healthcare settings. Growing preference for minimally invasive therapy management also boosts this segment’s prominence.
- For instance, ResMed reported in October 2024 that it has over 27 million cloud-connectable devices in the market and monitors over 29.5 million patients in its AirView software ecosystem.
By End Use
The home healthcare segment accounted for the largest share of 47% in 2024, supported by a shift toward patient-centric care and the rising geriatric population. Increased adoption of home-based medical equipment, including oxygen concentrators, mobility aids, and monitoring systems, enhances patient convenience and reduces hospital readmissions. Advancements in telehealth and remote monitoring technologies allow effective chronic disease management outside clinical settings. Favorable reimbursement policies for durable medical equipment and growing awareness of cost-effective home treatment solutions further support segment leadership.
- For instance, Lincare serves ~1.8 million patients through 700+ U.S. locations.
Key Growth Drivers
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic illnesses such as diabetes, cardiovascular diseases, and respiratory disorders is a major driver for the durable medical equipment market. Demand for oxygen therapy systems, infusion pumps, and glucose analyzers continues to grow with the expanding patient base. The need for continuous monitoring and long-term therapy management supports steady adoption across healthcare facilities and home care settings. This shift toward proactive and sustained treatment approaches significantly enhances the market’s overall growth potential.
- For instance, Dexcom ended 2024 with about 2.8–2.9 million CGM users worldwide.
Expanding Home Healthcare Adoption
Growing preference for home-based medical care drives strong demand for portable and user-friendly equipment. Patients and caregivers increasingly rely on wheelchairs, oxygen concentrators, and monitoring devices for at-home recovery and chronic disease management. Cost-effectiveness, convenience, and improved patient comfort are key motivators for adoption. Supportive insurance coverage and reimbursement policies for home healthcare further accelerate equipment deployment across aging populations and individuals requiring long-term care.
- For instance, Baxter’s Novum IQ LVP maintains accuracy up to 96 hours and 12 liters per set.
Technological Advancements in Equipment Design
Rapid innovation in device connectivity, ergonomics, and functionality is enhancing the performance of durable medical equipment. The integration of IoT and AI technologies enables real-time health monitoring and predictive maintenance. Lightweight materials and compact designs improve portability and user experience. Manufacturers focus on developing wireless and smart-enabled devices to improve diagnostic accuracy and treatment efficiency, driving greater adoption in both clinical and home environments.
Key Trends and Opportunities
Shift Toward Remote Patient Monitoring
The expansion of telehealth and connected devices creates new opportunities for remote patient management. Healthcare providers increasingly use DME integrated with digital platforms for continuous monitoring of vital signs. Real-time data exchange enables early detection of health issues and reduces hospital visits. This trend is supported by growing digital infrastructure, wider acceptance of remote care, and increased investment in health technology innovation.
- For instance, Abbott’s FreeStyle Libre systems now serve ~7 million users across 60+ countries; GLP-1 plus Libre users saw HbA1c drop by 2.4%.
Sustainability and Reusability Focus
Manufacturers are focusing on sustainable designs and recyclable materials to reduce medical waste and operational costs. Reusable wheelchairs, eco-friendly catheters, and energy-efficient monitors are gaining traction. Governments and healthcare institutions encourage green procurement policies, creating incentives for sustainable product development. This focus on environmental responsibility aligns with global healthcare sustainability goals and drives innovation across production and supply chains.
- For instance, Boston Scientific reported 2024 UK emissions of 4,067 tCO₂e (Scope 1: 883; Scope 2: 53; Scope 3: 3,131).
Growing Penetration of Smart Mobility Aids
Smart mobility devices with automated control and tracking features are emerging as a new growth avenue. Advanced wheelchairs and walkers equipped with sensors and navigation systems improve patient mobility and safety. These devices are becoming integral to rehabilitation and eldercare programs. Rising investment in assistive robotics and AI-powered devices further expands opportunities for next-generation DME solutions.
Key Challenges
High Equipment and Maintenance Costs
The significant cost of advanced medical equipment limits access in low-income regions and among uninsured patients. Frequent maintenance requirements and replacement parts add to operational expenses for healthcare providers. Despite reimbursement support, affordability remains a challenge for small clinics and home users. These cost-related barriers slow adoption, especially for high-end monitoring and therapeutic devices.
Regulatory and Compliance Barriers
Strict regulatory requirements for product approval and quality standards delay market entry for new manufacturers. Compliance with medical device directives, safety testing, and post-market surveillance increases development costs. Differences in regional approval frameworks further complicate international expansion. These complex regulatory environments pose a challenge to timely product launches and restrict smaller players from entering competitive markets.
Regional Analysis
North America
North America held the largest share of 38% in the durable medical equipment market in 2024. The region’s dominance is driven by advanced healthcare infrastructure, strong insurance coverage, and high adoption of home-based care solutions. Rising prevalence of chronic diseases such as diabetes and respiratory disorders fuels demand for oxygen concentrators, infusion pumps, and glucose monitoring systems. Key manufacturers focus on product innovation and regulatory compliance to maintain market leadership. Additionally, aging populations and government support for telehealth and mobility devices continue to strengthen the region’s market growth prospects.
Europe
Europe accounted for a 29% share of the durable medical equipment market in 2024. The region benefits from widespread access to advanced medical technologies and well-structured reimbursement systems. Increasing healthcare spending and growing emphasis on elderly care drive strong adoption of mobility aids and monitoring equipment. Countries such as Germany, the United Kingdom, and France lead in deploying portable therapeutic devices. The European Union’s initiatives promoting sustainable and energy-efficient medical devices further support market expansion. Rising demand for home healthcare solutions contributes significantly to steady regional growth.
Asia Pacific
Asia Pacific held a 23% share of the durable medical equipment market in 2024, emerging as the fastest-growing region. Rapid urbanization, expanding healthcare infrastructure, and increasing government investments in elderly care are key growth enablers. Rising awareness of chronic disease management drives adoption of oxygen equipment, vital sign monitors, and mobility aids. Countries such as China, Japan, and India are witnessing growing demand for affordable, portable devices. Expanding home healthcare services and technological advancements in patient monitoring systems are accelerating market penetration across developing economies in the region.
Latin America
Latin America captured a 6% share of the durable medical equipment market in 2024. The region’s growth is supported by expanding healthcare access, particularly in Brazil, Mexico, and Argentina. Public health programs promoting home care and rehabilitation are driving demand for wheelchairs, walkers, and oxygen concentrators. Increasing partnerships with global manufacturers enhance product availability and affordability. Despite infrastructure and cost challenges, growing investments in private healthcare facilities are improving the adoption of medical furniture, diagnostic tools, and chronic disease management equipment.
Middle East and Africa
The Middle East and Africa accounted for a 4% share of the durable medical equipment market in 2024. Regional growth is driven by increasing healthcare modernization, particularly in Saudi Arabia, the United Arab Emirates, and South Africa. Rising prevalence of chronic conditions and expanding elderly populations create demand for mobility and therapeutic devices. Governments are prioritizing healthcare digitalization and hospital infrastructure upgrades, boosting the adoption of durable medical solutions. However, limited reimbursement frameworks and cost barriers still restrict large-scale deployment across low-income nations within the region.
Market Segmentations:
By Product
- Personal mobility devices
- Wheelchair and scooter
- Crutches and canes
- Walkers
- Other personal mobility devices
- Monitoring and therapeutic devices
- Oxygen equipment
- Blood glucose analyzers
- Vital sign monitors
- Infusion pumps
- Continuous positive airway pressure (CPAP) devices
- Nebulizers
- Other monitoring and therapeutic devices
- Bathroom safety devices
- Medical furniture
- Incontinent pads
- Breast pumps
- Catheters
- Consumables and accessories
- Other products
By End Use
- Hospitals
- Home healthcare
- Ambulatory surgical centers
- Other end-users
By Geography
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Competitive Landscape
The durable medical equipment market is characterized by intense competition among leading players such as Medtronic PLC, General Electric Company, Becton, Dickinson and Company, Stryker Corporation, Hill Rom, Inc., Getinge AB, Resmed Inc., React Health, ArjoHuntleigh, Drive Medical, Invacare Corporation, Sunrise Medical, Medline Industries, GF Health Products, Inc., Carex Health Brands, Inc., and Compass Health Brands. These companies focus on technological advancement, product innovation, and portfolio diversification to enhance market presence. They compete through development of lightweight, connected, and patient-centric devices that improve usability and performance. Strategic partnerships and mergers expand global distribution networks and strengthen after-sales support. Increasing investment in sustainable materials and smart monitoring solutions aligns with evolving healthcare and environmental standards, while the growing emphasis on home healthcare and telemonitoring continues to shape competitive strategies across the industry.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Key Player Analysis
- Medtronic PLC
- General Electric Company
- Becton, Dickinson and Company
- Stryker Corporation
- Hill Rom, Inc.
- Getinge AB
- Resmed Inc.
- React Health
- ArjoHuntleigh
- Drive Medical
- Invacare Corporation
- Sunrise Medical
- Medline Industries
- GF Health Products, Inc.
- Carex Health Brands, Inc.
- Compass Health Brands
Recent Developments
- In 2025, Invacare Corporation Unveiled the Limited Edition Küschall Element wheelchair at Autonomic Paris.
- In 2024, Stryker has introduced the Tornier shoulder arthroplasty portfolio in India and launched its first new Tornier product, the Perform Humeral Stem
- In 2023, React Health acquired Invacare’s respiratory product portfolio, including its portable and stationary oxygen concentrators, after Invacare had ceased producing these products in late 2022.
Report Coverage
The research report offers an in-depth analysis based on Product, End-Use and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- Rising chronic disease prevalence will continue to drive long-term demand for durable medical equipment.
- Home healthcare adoption will expand due to aging populations and preference for cost-effective care.
- Integration of IoT and AI technologies will enhance remote monitoring and device efficiency.
- Manufacturers will focus on lightweight, portable, and patient-friendly device designs.
- Expansion of telehealth platforms will strengthen connectivity between patients and healthcare providers.
- Sustainability initiatives will encourage development of reusable and eco-friendly medical devices.
- Government reimbursement programs will improve accessibility for patients and care facilities.
- Emerging economies will witness faster adoption due to healthcare infrastructure upgrades.
- Strategic partnerships between manufacturers and digital health firms will accelerate innovation.
- Increasing focus on personalized and preventive care will shape future product development.
